Global Active Pharmaceutical Ingredients Market Research Report: Information by Manufacturing Process (Captive Manufacturing and Contract Manufacturing), Type of Synthesis (Synthetic and Biotech), by API Formulation (Generic API and Branded/Innovative API), Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology and others), Molecules (Large Molecule and Small Molecule) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2023

The Global Active Pharmaceutical Ingredients Market Overview shows market is expected to exhibit a strong 4.96% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). According to MRFR, the global active pharmaceutical ingredients market is expected to reach a valuation of USD 215,125.4 million by 2023.

Active pharmaceutical ingredients comprise the pharmaceutically active agent in any medicine, i.e. the product that actively has an effect on the disease and helps cure it. The growing prevalence of chronic diseases such as cardiovascular diseases (CVDs) and cancer is likely to be the major driver for the global active pharmaceutical ingredients market over the forecast period. The growing healthcare industry and biotech sector are also likely to be major drivers for the active pharmaceutical ingredients market, as drug development has emerged as a major target for players operating in these fields. Growing revenue streams from the healthcare sector have propelled drug development efforts in the biotechnology sector. Finding effective cures for various cancers has also emerged as a major objective for players in the active pharmaceutical ingredients market over the last few years. This is likely to remain a major driver for the active pharmaceutical ingredients market over the forecast period, as the prevalence of cancer is likely to grow over the forecast period.

The increasing importance of generics is likely to be a key trend in the global active pharmaceutical ingredients market over the forecast period. Generics are copies of branded drugs that can be sold at much lower prices due to the absence of a copyright. These have become vital for the healthcare sector, especially in developing countries, due to the high prices of branded drugs. Many consumers in developing, middle-income and low-income countries can’t afford branded drugs, however dire their need. This has driven the production of generics across the board, as companies have tried to cash in on the growing need for effective APIs in developing economies. The rising uptake of biopharmaceuticals in countries across the world is also likely to be a major driver for the global active pharmaceutical ingredients market over the forecast period. The rising demand to make pharmaceutical ingredients safe and biologically sourced is likely to drive the demand for biopharmaceuticals over the forecast period.

Active Pharmaceutical Ingredients Market Competitive Analysis:

Leading players in the global active pharmaceutical ingredients market include Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Merck & Co. Inc., Bayer AG, Abbott, Pfizer Inc., F. Hoffman-La Roche Ltd., and Sanofi SA.

In November 2019, Teva announced that production at its Italy plant will be shut down until the new year due to regulatory compliances.

Browse More Information @ https://www.marketresearchfuture.com/reports/active-pharmaceutical-ingredients-market-1385

Active Pharmaceutical Ingredients Market Segmentation:

The global active pharmaceutical ingredient market is segmented on the basis of manufacturing process, type of synthesis, API formulation, application, molecule size, and region.

By manufacturing process, the global active pharmaceutical ingredients market is segmented into captive manufacturing and contract manufacturing.

By type of synthesis, the global active pharmaceutical ingredients market is segmented into synthetic and biotech. The biotech segment is further sub-segmented into monoclonal antibodies, recombinant proteins, vaccines, and others.

By API formulation, the global active pharmaceutical ingredients market is segmented into generic API and branded/innovative API.

By application, the global active pharmaceutical ingredients market is segmented into cardiovascular diseases, oncology, neurological disorders, orthopedic disorders, respiratory disorders, gastrointestinal disorders, urology, and others. The CVD, oncology, and neurological disorders segments collectively account for more than half of the global active pharmaceutical ingredients market, with the cardiovascular segment holding the leading share.

By molecule, the global active pharmaceutical ingredients market is segmented into large molecule and small molecule.

Active Pharmaceutical Ingredients Market Regional Analysis:

The Americas is expected to dominate the global active pharmaceutical ingredients market, followed by Europe. Asia Pacific is expected to exhibit the fastest growth in the active pharmaceutical ingredients market over the forecast period due to the growing active pharmaceutical ingredients industry in Japan, China, and India, among other countries.